Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”
Chemical Biology & Drug Design · 2026-07 · 108 (1)
DOI: 10.1111/cbdd.70357 ↗Kurz gefasst
Korrektur in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 09.07.2026.
Abstract (Originalsprache)
Sonawane, N. G., Thakur, A., Pillai, A. K. S., Sharma, A., Gunjal, A. P., & Sharma, K. (2024). “Recent Cutting-Edge Designing Strategies for Mtb-DHFR Inhibitors as Antitubercular Agents.” Chemical Biology & Drug Design 104, no. 6: e70027. The affiliation of the authors Nitin Govind Sonawane, Amrita Thakur, Anil Kumar Sasidharan Pillai, and Amol Pandurang Gunjal was incorrect and has been corrected to Department of Physical Sciences, Amrita School of Engineering, Amrita Vishwa Vidyapeetham, Bengaluru Campus, India. The online version of this article has been corrected accordingly. We apologize for this error.
Zitieren
APA
(2026). Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”. Chemical Biology & Drug Design, 108(1). https://doi.org/10.1111/cbdd.70357
Vancouver
Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”. Chemical Biology & Drug Design. 2026;108(1). doi:10.1111/cbdd.70357
BibTeX
@article{euvimed2026,
title = {Correction to “Recent Cutting‐Edge Designing Strategies for Mtb‐DHFR Inhibitors as Antitubercular Agents”},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {108},
number = {1},
doi = {10.1111/cbdd.70357}
}
EUVIMED